{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:29:17Z","timestamp":1789270157040,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T00:00:00Z","timestamp":1481328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12282-016-0746-8","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T08:30:06Z","timestamp":1481358606000},"page":"601-607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis"],"prefix":"10.1007","volume":"24","author":[{"given":"Seiya","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shiozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"On","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,10]]},"reference":[{"key":"746_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American society for bone and mineral research. J Bone Miner Res. 2014;29:1\u201323.","journal-title":"J Bone Miner Res"},{"key":"746_CR2","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25:2267\u201394.","journal-title":"J Bone Miner Res"},{"key":"746_CR3","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90:1294\u2013301.","journal-title":"J Clin Endocrinol Metab"},{"key":"746_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/17453674.2013.854668","volume":"85","author":"E Drampalos","year":"2014","unstructured":"Drampalos E, Skarpas G, Barbounakis N, Michos I. Atypical femoral fractures bilaterally in a patient receiving denosumab. Acta Orthop. 2014;85:3\u20135.","journal-title":"Acta Orthop"},{"key":"746_CR5","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00198-008-0816-7","volume":"20","author":"T Matsumoto","year":"2009","unstructured":"Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, et al. Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int. 2009;20:1429\u201337.","journal-title":"Osteoporos Int"},{"key":"746_CR6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","volume":"98","author":"LS Rosen","year":"2003","unstructured":"Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer. 2003;98:1735\u201344.","journal-title":"Cancer"},{"key":"746_CR7","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","volume":"21","author":"LS Rosen","year":"2003","unstructured":"Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, Krzakowski M, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial\u2014the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol. 2003;21:3150\u20137.","journal-title":"J Clin Oncol"},{"key":"746_CR8","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","volume":"23","author":"N Kohno","year":"2005","unstructured":"Kohno N, Aogi K, Minami H, Nakamura S, Asaga T, Iino Y, et al. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol. 2005;23:3314\u201321.","journal-title":"J Clin Oncol"},{"key":"746_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","volume":"49","author":"RE Coleman","year":"2011","unstructured":"Coleman RE, McCloskey EV. Bisphosphonates in oncology. Bone. 2011;49:71\u20136.","journal-title":"Bone"},{"key":"746_CR10","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0020-1383(07)80005-2","volume":"38S","author":"JP Fr\u00f6lke","year":"2007","unstructured":"Fr\u00f6lke JP, Patka P. Definition and classification of fracture non-unions. Injury. 2007;38S:S19\u201322.","journal-title":"Injury"},{"key":"746_CR11","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","volume":"364","author":"J Schilcher","year":"2011","unstructured":"Schilcher J, Micha\u00eblsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011;364:1728\u201337.","journal-title":"N Engl J Med"},{"key":"746_CR12","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","volume":"362","author":"DM Black","year":"2010","unstructured":"Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362:1761\u201371.","journal-title":"N Engl J Med"},{"key":"746_CR13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2106\/JBJS.J.01199","volume":"93","author":"ME Puhaindran","year":"2011","unstructured":"Puhaindran ME, Farooki A, Steensma MR, Hameed M, Healey JH, Boland PJ. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates. J Bone Joint Surg Am. 2011;93:1235\u201342.","journal-title":"J Bone Joint Surg Am"},{"key":"746_CR14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bone.2012.05.010","volume":"51","author":"ST Chang","year":"2012","unstructured":"Chang ST, Tenforde AS, Grimsrud CD, O\u2019Ryan FS, Gonzalez JR, Baer DM, et al. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Bone. 2012;51:524\u20137.","journal-title":"Bone"},{"key":"746_CR15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","volume":"305","author":"LY Park-Wyllie","year":"2011","unstructured":"Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, et al. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA. 2011;305:783\u20139.","journal-title":"JAMA"},{"key":"746_CR16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00774-014-0606-6","volume":"33","author":"KS Khow","year":"2015","unstructured":"Khow KS, Yong TY. Atypical femoral fracture in a patient treated with denosumab. J Bone Miner Metab. 2015;33:355\u20138.","journal-title":"J Bone Miner Metab"},{"key":"746_CR17","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2106\/JBJS.N.00075","volume":"96","author":"JE Hagen","year":"2014","unstructured":"Hagen JE, Miller AN, Ott SM, Gardner M, Morshed S, Jeray K, et al. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry. J Bone Joint Surg Am. 2014;96:1905\u20139.","journal-title":"J Bone Joint Surg Am"},{"key":"746_CR18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00776-014-0572-9","volume":"19","author":"Y Oh","year":"2014","unstructured":"Oh Y, Wakabayashi Y, Kurosa Y, Ishizuki M, Okawa A. Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series. J Orthop Sci. 2014;19:579\u201386.","journal-title":"J Orthop Sci"},{"key":"746_CR19","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1007\/s11999-010-1583-2","volume":"468","author":"YC Ha","year":"2010","unstructured":"Ha YC, Cho MR, Park KH, Kim SY, Koo KH. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy? Clin Orthop Relat Res. 2010;468:3393\u20138.","journal-title":"Clin Orthop Relat Res"},{"key":"746_CR20","doi-asserted-by":"crossref","unstructured":"Oh CW, Oh JK, Park KC, Kim JW, Yoon YC. Prophylactic nailing of incomplete atypical femoral fractures. Sci World J. 2013.","DOI":"10.1155\/2013\/450148"},{"key":"746_CR21","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1007\/s11999-013-2963-1","volume":"472","author":"KA Egol","year":"2014","unstructured":"Egol KA, Park JH, Rosenberg ZS, Peck V, Tejwani NC. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails. Clin Orthop Relat Res. 2014;472:2728\u201334.","journal-title":"Clin Orthop Relat Res"},{"key":"746_CR22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3928\/01477447-20120525-51","volume":"35","author":"MK Grady","year":"2012","unstructured":"Grady MK, Watson JT, Cannada LK. Treatment of femoral fracture nonunion after long-term bisphosphonate use. Orthopedics. 2012;35:991\u20135.","journal-title":"Orthopedics"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-016-0746-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-016-0746-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-016-0746-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T14:42:46Z","timestamp":1498142566000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-016-0746-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s12282-016-0746-8","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,10]]}}}